These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 9179223

  • 21. Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
    Zamora PO, Bender H, Knapp FF, Rhodes BA, Biersack HJ.
    Hybridoma; 1997 Feb; 16(1):85-91. PubMed ID: 9085134
    [Abstract] [Full Text] [Related]

  • 22. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 23. Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs.
    Hosono M, Hosono MN, Haberberger T, Zamora PO, Guhlke S, Bender H, Knapp FF, Biersack HJ.
    Jpn J Cancer Res; 1996 Sep; 87(9):995-1000. PubMed ID: 8878464
    [Abstract] [Full Text] [Related]

  • 24. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
    Emfietzoglou D, Kostarelos K, Sgouros G.
    J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
    Miao Y, Owen NK, Fisher DR, Hoffman TJ, Quinn TP.
    J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL.
    Prostate; 2002 Aug 01; 52(3):173-82. PubMed ID: 12111694
    [Abstract] [Full Text] [Related]

  • 27. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJ, Boerman OC.
    J Nucl Med; 2004 Jul 01; 45(7):1224-32. PubMed ID: 15235070
    [Abstract] [Full Text] [Related]

  • 28. Candidates for peptide receptor radiotherapy today and in the future.
    Reubi JC, Mäcke HR, Krenning EP.
    J Nucl Med; 2005 Jan 01; 46 Suppl 1():67S-75S. PubMed ID: 15653654
    [Abstract] [Full Text] [Related]

  • 29. Radiopharmacokinetic and dosimetric parameters of 188Re-lanreotide in athymic mice with induced human cancer tumors.
    Molina-Trinidad EM, de Murphy CA, Ferro-Flores G, Murphy-Stack E, Jung-Cook H.
    Int J Pharm; 2006 Mar 09; 310(1-2):125-30. PubMed ID: 16423478
    [Abstract] [Full Text] [Related]

  • 30. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
    Schottelius M, Rau F, Reubi JC, Schwaiger M, Wester HJ.
    Bioconjug Chem; 2005 Mar 09; 16(2):429-37. PubMed ID: 15769098
    [Abstract] [Full Text] [Related]

  • 31. Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo.
    Palakurthi S, Wilson J, McQuarrie SA, Suresh MR, Mercer JR, Miller GG.
    In Vivo; 2008 Mar 09; 22(3):321-6. PubMed ID: 18610743
    [Abstract] [Full Text] [Related]

  • 32. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M, Behr TM.
    Biopolymers; 2002 Mar 09; 66(6):399-418. PubMed ID: 12658727
    [Abstract] [Full Text] [Related]

  • 33. Perspectives of new potential therapeutic applications of somatostatin analogs.
    Pawlikowski M, Melen-Mucha G.
    Neuro Endocrinol Lett; 2003 Mar 09; 24(1-2):21-7. PubMed ID: 12743527
    [Abstract] [Full Text] [Related]

  • 34. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Volkert WA, Hoffman TJ.
    Anticancer Res; 2003 Mar 09; 23(1A):63-70. PubMed ID: 12680195
    [Abstract] [Full Text] [Related]

  • 35. Uptake of the 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry.
    García-Salinas L, Ferro-Flores G, Arteaga-Murphy C, Pedraza-López M, Hernández-Gutiérrez S, Azorin-Nieto J.
    Appl Radiat Isot; 2001 Mar 09; 54(3):413-8. PubMed ID: 11214875
    [Abstract] [Full Text] [Related]

  • 36. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model.
    Hsu WH, Liu SY, Chang YJ, Chang CH, Ting G, Lee TW.
    Nucl Med Biol; 2014 Oct 09; 41(9):765-71. PubMed ID: 25027866
    [Abstract] [Full Text] [Related]

  • 37. 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy.
    Das T, Banerjee S, Samuel G, Sarma HD, Ramamoorthy N, Pillai MR.
    Nucl Med Commun; 2000 Oct 09; 21(10):939-45. PubMed ID: 11130335
    [Abstract] [Full Text] [Related]

  • 38. Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice.
    Hosono MN, Hosono M, Zamora PO, Guhlke S, Haberberger T, Bender H, Knapp FF, Biersack HJ.
    Ann Nucl Med; 1998 Apr 09; 12(2):83-8. PubMed ID: 9637278
    [Abstract] [Full Text] [Related]

  • 39. Labeling and quality control of 188Re-lanreotide.
    Verdera S, Balter H, Rodríguez G, Oliver P, Souto B, López A, Goncalvez Z.
    Cell Mol Biol (Noisy-le-grand); 2002 Nov 09; 48(7):741-5. PubMed ID: 12619968
    [Abstract] [Full Text] [Related]

  • 40. Rhenium-188--a generator-derived radioisotope for cancer therapy.
    Knapp FF.
    Cancer Biother Radiopharm; 1998 Oct 09; 13(5):337-49. PubMed ID: 10851424
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.